ISSN: 2332-0877

Journal of Infectious Diseases & Therapy
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Mini Review   
  • J Infect Dis Ther 2019, Vol 7(3): 403
  • DOI: 10.4172/2332-0877.1000403

Macrolide Treatment and Personalized Medicine in Japan

Masafumi Seki*
Division of Infectious Diseases and Infection Control, Tohoku Medical and Pharmaceutical University Hospital, Sendai City, Miyagi, Japan
*Corresponding Author : Masafumi Seki, Division of Infectious Diseases and Infection Control, Tohoku Medical and Pharmaceutical University Hospital, Sendai City, Miyagi, Japan, Tel: +81-22-259-122, Email: m-seki@tohoku-mpu.ac.jp

Received Date: Apr 29, 2019 / Accepted Date: May 13, 2019 / Published Date: May 20, 2019

Abstract

Macrolides are known as antibiotics, but also have various actions, including immunomodulatory effects. Recently, they were suggested that effectiveness for acute infectious diseases, such as influenza and pneumococcal pneumonia by inhibited of cytokines and toxins in addition to chronic infectious diseases like mycobacterium and pseudomonas infection.

They show few allergic reactions and can contribute to more effective relief of symptoms and inhibition of the development of resistance to other antibacterial agents in Japan.

Keywords: Macrolide; Japan, Influenza; Streptococcus pneumonia; Pseudomonas aeruginosa

Citation: Seki M (2019) Macrolide Treatment and Personalized Medicine in Japan. J Infect Dis Ther 7: 403. Doi: 10.4172/2332-0877.1000403

Copyright: © 2019 Seki M, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Top